Breast Oncologist with focus on genetic

The Oncology Division in the Department of Internal Medicine (DOIM) in the Spencer Fox Eccles School of Medicine, at the University of Utah and Huntsman Cancer Institute (HCI) are recruiting an outstanding clinician specializing in evaluation and management of individuals with cancer or at high risk for developing breast and other cancers based on genetic or familial risk. Applicants are encouraged from Assistant, Associate or Full Professors in the clinical or tenure track to provide clinical care and lead clinical or translational research in our main campus, community, and affiliate hospital locations.The candidate will join a highly collaborative team of physicians, genetic counselors, and population scientists in the Family Cancer Assessment Clinic at the Huntsman Cancer Institute. The position would involve providing clinical care in the hereditary cancer clinic that serves affected and at-risk individuals with a diverse range of hereditary cancer syndromes and continuing or developing a related research program.This position is part of HCIs strategic priority to provide fully integrated, high value cancer care across the Intermountain West. As part of a growing translational research initiative, the successful candidate will have an opportunity to participate in multidisciplinary teams to develop clinical research programs. Institute members do research to improve understanding and management of these high-risk breast cancers, with the broad goals of improving cancer prevention, diagnosis, treatment and survival, expanding genetic testing for those predisposed to cancer, identifying cancers that are likely to spread, overcoming barriers to screening, and expanding community outreach activities and remaining dedicated to involving the community and listening to our patients.Minimum Qualifications: Must be board certified or eligible to be board certified in oncology or gastroenterology and eligible for a Utah medical license. The successful candidate will preferably have established or show promise of establishing a clinical and/or translational research career in high-risk cancer research or cancer genetics.Preferred Qualifications: National or international research reputation, clinical leadership, and progressive administrative experience.Please apply by submitting a current curriculum vitae, a cover letter containing a description of professional experiences, including leadership responsibilities, scientific accomplishments, clinical practice, mentoring, administrative/service experiences at: https://utah.peopleadmin.com/postings/173047Please send inquiries to Erica Adamson at erica.adamson@utah.eduThe University of Utah Health has ranked in the top 10 of the prestigious Vizient Quality Leadership Award for the last 13 years. The University of Utah is also a Top-Tier 1 research (R1) institution and a member of the Association of American Universities. Its research funding was $768 million in FY23. The Spencer Fox Eccles School of Medicine had $312 million in funding this year with the departments of Internal Medicine (DOIM) and Pediatrics contributing over $113 million, followed by the departments of Biochemistry and Neurology contributing over $42 million.For more than seventy-five years, the DOIM has had a rich history of providing excellent care, quality research, and valuable education in Utah. DOIM is a collaborative Department, with strong partnerships among divisions, across departments, and with the VA Hospital and HCI. Further, the DOIM has a strong research focus with $126.8M total research funding and $48.3 M in total NIH funding in Fiscal Year 2024. The DOIM has also seen double-digit clinical growth for several years.HCI is an NCI -Designated Comprehensive Cancer Center and a member of the National Comprehensive Cancer Network (NCCN), supporting and fostering a vibrant cancer research enterprise in a highly collegial environment. HCI has an outstanding history of academic achievement and impact, with $2 1K in cancer research and 325 open clinical trials in Fiscal Year 2024. HCI has a collaborative environment, and a commitment to excellence in patient care, research, teaching, training, community engagement, and service.The Division of Oncology is one of twelve divisions within the Department of Internal Medicine (DOIM). The faculty and advanced practice clinicians cover the entire spectrum of oncology and are dedicated to high quality, value-driven patient care, education, and innovation and discovery through basic, clinical, population, and health services research. The Division Oncology is aligned with the Huntsman Cancer Institute (HCI), an NCI-designated Comprehensive Cancer Center serving a large geographic area. The DOIM and HCI are undergoing major expansions of their clinical and research operations and are committed to supporting the growth of the Oncology Division through recruitment of new clinical, translational, and laboratory-based faculty.The University of Utah Health (U of U Health) is a patient focused center distinguished by collaboration, excellence, leadership, and respect. The U of U Health values candidates who are committed to fostering and furthering the culture of compassion, collaboration, innovation, accountability, acceptance, integrity, quality, and trust that is integral to our mission.